We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clinigen Group Plc | LSE:CLIN | London | Ordinary Share | GB00B89J2419 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 925.00 | 924.50 | 925.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/10/2015 16:06 | CFO sells 2/5 of his shares. Other directors cash-in options rather than keeping shares. I'd say thats a fairly clear signal to the market... | phowdo | |
07/10/2015 16:00 | We seem to be having a wee bit of a sell off recently. | rjd1233 | |
06/10/2015 08:46 | Any one know anything about the present situation with regard to the Slater holding here please? | gswredland | |
03/10/2015 13:05 | AIM Awards 2015 Shortlist: Company of the Year Award Sponsored by | WH Ireland Clinigen Group plc CVS Group plc Dart Group plc James Halstead plc | aishah | |
01/10/2015 13:17 | And a jim slater fav Targets about £10 if I remember right | gucci | |
01/10/2015 11:19 | Thanks for that AISHAH | gucci | |
01/10/2015 11:01 | SharesMag cover CLIN today saying huge profit growth fcst and current rating justified. | aishah | |
01/10/2015 10:30 | Back in Next leg up started | gucci | |
28/9/2015 15:59 | whoa what happened? nothing on news - problem with acquisition or just had a good run | slogsweep | |
22/9/2015 15:06 | Video interview with Deputy CEO Chilton Shaun Chilton, deputy chief executive of Clinigen (LON:CLIN), says the firm’s purchase of Link Healthcare gives the group access to future growth markets - one of Clinigen’s key strategic objectives. Dutch-based Link distributes niche pharmaceuticals across Africa, Asia, Australasia and Clinigen is paying £44.5mln upfront for the business. A further £55.5mln will be handed out over the next two years, subject to Link hitting certain targets. Clinigen also told investors today that its own underlying EBITDA in the year to June rose a fifth to £32.3mln on a 45% increase in revenue to £184.4mln. | proactivest | |
22/9/2015 11:22 | Numis reiterate BUY and 905p target | aishah | |
22/9/2015 08:01 | These results suggest we will see new ath today. Don't think market has has sufficiently factored in benefits of the Idis acquisition but becoming clearer now with these results. Peel Hunt tp of £10 not looking silly anymore. RM | rampmeister | |
22/9/2015 07:57 | A lot is happening with this company! Excellent results as always and a large acquisition announced to. This should break out today into new territory! Director talks about the acquisition here: happy holding | mg1982 | |
17/9/2015 07:25 | Excellent alliance with Cumberland to give US market sales and marketing promotion to drive growth of our product portfolio. Would expect to see a move upwards and the £8 target reached by month end. | adorling | |
07/8/2015 13:32 | I dare say we are seeing a brief breather in the share price advance before we attempt the next target of eight quid. | cfro | |
07/8/2015 12:16 | Some large sells going through today. They've heard that I increased yesterday :-( apad | apad | |
05/8/2015 13:44 | Share price getting steeper by the day...:0)) | cfro | |
31/7/2015 10:20 | Up again today.. | cfro | |
30/7/2015 15:43 | wow Qp. also look ready to go north | albanyvillas | |
30/7/2015 14:25 | Large sale volumes today. apad | apad | |
29/7/2015 11:34 | N+1 Singer retains BUY and 800p target | aishah | |
29/7/2015 10:46 | New highs here and through 7 pounds.... | cfro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions